ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 190 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q3 2023. The put-call ratio across all filers is 0.86 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,054,537 | -19.5% | 193,493 | -0.9% | 0.00% | 0.0% |
Q2 2023 | $1,309,711 | -26.3% | 195,188 | -3.0% | 0.00% | -33.3% |
Q1 2023 | $1,777,620 | +10.9% | 201,316 | -4.1% | 0.00% | 0.0% |
Q4 2022 | $1,603,147 | +7.3% | 209,836 | -0.1% | 0.00% | 0.0% |
Q3 2022 | $1,494,000 | -13.6% | 209,954 | -1.8% | 0.00% | 0.0% |
Q2 2022 | $1,730,000 | +15.5% | 213,782 | +589.3% | 0.00% | 0.0% |
Q2 2019 | $1,498,000 | – | 31,013 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Eagle Health Investments LP | 1,014,860 | $14,086,000 | 3.47% |
Triatomic Management LP | 297,048 | $4,123,000 | 3.35% |
Diametric Capital, LP | 265,000 | $3,678,000 | 2.03% |
Matrix Capital Management Company, LP | 11,572,590 | $160,628,000 | 1.93% |
VIKING GLOBAL INVESTORS LP | 29,993,708 | $416,313,000 | 1.68% |
TIGER MANAGEMENT L.L.C. | 589,311 | $8,180,000 | 1.35% |
Aristotle Atlantic Partners, LLC | 759,412 | $10,541,000 | 0.65% |
Casdin Capital, LLC | 1,000,000 | $13,880,000 | 0.62% |
Pier Capital, LLC | 339,541 | $4,713,000 | 0.60% |
Leeward Financial Partners, LLC | 68,504 | $951,000 | 0.59% |